How to lose visceral fat: Anti-diabetic medication shown to reduce belly fat in research

Fitness & Health:

Exercise is the key way to shed visceral fat – as long as your heartbeat is racing, and you’re working up a sweat, you can be sure that the body is losing some visceral fat. But what about if you could just take a pill? In a virtual video conference, researchers at the Endocrine Society’s annual meeting ENDO 2021 proposed that semaglutide reduces excessive body fat. Lead researcher, Professor John Wilding, said: “Our findings suggest that semaglutide, through body weight loss and improvement of body composition, has the potential to reduce the risk of heart disease, diabetes and stroke.”

The STEP 1 study included 1,961 adults with a body mass index (BMI) of 27 or higher, meaning they were classified as “overweight”.

All participants had at least one weight-related health condition, not including diabetes.

Study participants were randomly assigned to inject themselves once weekly with 2.4mg of semaglutide or a placebo for 68 weeks.


Semaglutide has already been approved by the US Food and Drug Administration at the lower dose of 1mg weekly to treat type 2 diabetes.

READ MORE: Hair loss treatment: Green tea could prevent balding and support hair growth

The drug is a synthetic version of the naturally occurring hormone glucagon-like peptide 1 (GLP1).

RELATED:  Covid new strain symptoms: Seven signs GPs want added to the official symptoms list

It acts on the appetite centres in the brain and gut, producing feelings of fullness.

Fat was measured by dual-energy absorptiometry (DEXA) – a technique that assesses body composition, body fat, and fat in the stomach area.

The researchers noted that participants assigned semaglutide had improved body composition, reduced body fat, and reduced belly fat.

Does Pfizer vaccine cause blood clots? [INSIGHT]Alcohol-related liver disease: Three signs [TIPS]Bowel cancer: Narrow poo is a visual sign [ADVICE]

The more weight the participant lost, the greater the improvement in body composition.

The results were published in The New England Journal of Medicine, showing that participants who injected semaglutide lost, on average, 15 percent of their body weight by the end of the trial.

In comparison, those who received a placebo lost an average of 2.4 percent after the year.

The participants who benefited from reduced fat levels also experienced improvements in risk factors for heart disease, diabetes and quality of life.

The use of Botox is synonymous with cosmetic procedures, known to help fill in wrinkles.

Yet, as time has gone on, Botox is now used as part of treatment plans for diseases such as Parkinson’s.

The charity Parkinson’s UK identified Botox as a potential treatment option for dystonia (i.e. muscle cramps).

“Botox is injected into your muscles to block the signals in your brain causing your dystonia,” explained the charity.

DISCLAIMER:-If article is on fitness, health tips, beauty, tips-tricks care like recommendation, then check for DISCLAIMER in T&C.

Health News Today & Latest Medical News More Updates

Today News || Latest News || World News || US Politics || Health News || Technology News || Education News


Show More

Related Articles

Back to top button